IL17A and aspergillosis: Some studies, on the contrary, provide evidence that outcome of aspergillosis in human is independent of TH17 responses [9], and the IL-23/IL-17A–driven inflammation could impede antifungal immune resistance and promote infection of A. fumigatus [27].